Meningococcal vaccine group C conjugate (Baxter/Pfizer)

C型脑膜炎球菌疫苗缀合物

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMeningococcal vaccine group C conjugate (Baxter/Pfizer)
Drug Alias NameNeisVac-C
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Conjugated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningitis, Meningococcal
Global Approved IndicationsMeningitis, Meningococcal
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date2000/07/01
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPfizer IncBaxter International Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Inc
Inactive CompaniesN/A
Active IndicationsMeningitis, Meningococcal
Inactive IndicationsN/A

Other Information

ATC CodeJ07AH07
Related LinksWikipedia